Indication

ELIGARD is a prescription drug, given by injection, for the management of advanced prostate cancer. However, there is no known cure for prostate cancer.
See Full Prescribing Information
For U.S. Residents Only
IMPORTANT SAFETY IMFORMATION

ELIGARD should not be used by women, children, or anyone who is allergic to the drug leuprolide acetate or any of the ingredients of ELIGARD. Leuprolide acetate can cause harm to the fetus if given to a pregnant woman.

ELIGARD, like other drugs in its class, causes a temporary increase in testosterone during the first and second weeks of treatment. Patients may experience worsening of symptoms or new symptoms during the first weeks of treatment, including bone pain, nerve damage, blood in the urine, pressure on the spine, or difficulty urinating. If your cancer has spread to the spine or urinary tract, urinary blockage or pressure in the spine may occur and can sometimes lead to paralysis, which may be fatal. You may require close medical attention during the first few weeks of therapy and you should notify your doctor if you develop any new or worsened symptoms after beginning treatment with ELIGARD.

The most common injection site side effects are temporary burning and stinging, pain, bruising and redness. The most common systemic adverse events include mild to severe hot flashes/sweats, fatigue, weakness, fever, muscle pain, testicular shrinkage and breast enlargement. For more information on these and other side effects, please talk to your doctor.

Glossary of Prostate Cancer Terms

A | B | C | D | E | F | G | H | I | J | K | L | M
N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A
Advanced prostate cancer: When prostate cancer spreads beyond the prostate to other parts of the body.
Androgens: Male hormones, such as testosterone.
Antiandrogens: Medications that block the testosterone receptor.
Atrophy: Wasting away or shrinkage.

B
Biopsy: The removal of a small piece of tissue, which is then examined under a microscope.
Bladder: A hollow organ that holds urine.

C
Cancer: A general term for a large group of diseases where a lack of controls on cell growth and division exists.
Cancer cells: Cells that grow and multiply abnormally and can spread to other parts of the body.
Chemotherapy: Treatment with drugs intended to kill cancer cells.
Clinical trials: Studies designed to test new ways to prevent or manage disease or its symptoms.
Combination therapy: When a doctor suggests combining treatments for maximum effect, such as radiation therapy combined with hormonal therapy or LHRH agonist combined with an antiandrogen.

D
Diagnose: Identify a disease by its signs and symptoms and then confirm with tests.
Digital Rectal Exam (DRE): A procedure in which the doctor inserts a gloved finger into the rectum to examine the rectum and the prostate gland for signs of disease.

E
Erectile dysfunction: The inability to have or maintain an erection.

F
Fatigue: Extreme tiredness.

G
Gastroenteritis: Inflammation of the stomach and intestines.
Gleason Score: A score (2-10) that helps doctors determine how aggressive prostate cancer is.
Gynecomastia: Swelling or enlargement of the breast.

H
Hormonal therapy: The use of medications or surgical removal of the endocrine glands to control hormone sensitive disease.
Hormones: Body chemicals secreted by glands that circulate in the bloodstream and produce specific effects on target organs and tissues, often distant from the site of their production.
Hot Flashes: A rush of warmth in the face, neck, upper chest, and back, lasting for a few seconds to an hour which may be accompanied by increased sweating.

I
Incontinence: The inability to control urine flow.
Infertility: The inability to produce viable sperm or eggs.

L
LHRH Agonist: An injectable substance which resembles the natural hormones that lead to the release of hormones which stimulate testosterone production. If it is given continuously, it will turn off testicular production of testosterone.
Leuprolide acetate: The active ingredient in ELIGARD™ (leuprolide acetate for injectable suspension).
Lymph nodes: Small glands that release cells to defend the body against harmful foreign particles.

M
Malaise: A nonspecific discomfort or feeling of uneasiness.
Male hormones: Substances, such as testosterone, that stimulate specific cells such as testicular and prostatic.
Metastasis: The spread of cancer cells to areas of the body beyond the organ of original occurrence.

O
Orchiectomy: Surgical removal of the testicles.

P
Prostate cancer: Cancer of the prostate gland. Prostate cancer can also spread to other parts of the body, such as lymph nodes, bone, and seminal vesicles.
Prostate gland: A male gland, located between the bladder and the penis, which surrounds the urethra.
Prostate-specific antigen: A substance produced by prostate cells.
PSA Level blood test: A blood test used in the detection and management of prostate disease.
Prostatectomy: Surgical removal of the prostate (see "Radical Prostatectomy").

R
Radiation therapy: The use of directed high-energy x-rays to kill cancer cells.
Radical prostatectomy: Surgery to remove the entire prostate gland along with the nearby tissue such as the seminal vesicles. (see "Prostatectomy").
Rectum: The final section of the intestines at the anus.

S
Semen: The thick, whitish fluid released through the penis during orgasm. The prostate makes substances that are in semen.
Seminal vesicles: A pair of glands, near the prostate, that add substances to semen.
Sperm: Male reproductive cells, produced in the testicles.
Staging: An evaluation of the extent of disease that provides the basis for making treatment recommendations.

T
Testes (Testicles): The pair of egg-shaped glands contained in the scrotum. They produce sperm and testosterone.
Testosterone: Stimulates a man's sexual activity and the growth of the sex organs, including the prostate.
Transrectal Ultrasound (TRUS): The use of sound waves to visualize the prostate.

U
Urethra: The duct that carries urine from the bladder.

W
Watchful Waiting: Monitoring of a patient by a physician instead of immediate treatment or intervention.

Quick Poll
If you are using ELIGARD, how often are your
injections?
every month
every 3 months
every 4 months
every 6 months
every month
 
  0%
every 3 months
 
  0%
every 4 months
 
  0%
every 6 months
 
  0%
Poll Image